DNA Script

📍 Le Kremlin-Bicêtre, France🗓 Founded 2014👥 243 employees💰 Last funded Dec 2020
Biotechnology Research🌐 dnascript.com
Website LinkedIn
DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAX™️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine.
6
Total investors
2
Early stage
3
Mid stage
1
Late stage
2014
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography4 countries
France
2
United States
2
Ireland
1
Netherlands
1
Investor activity2015–2020 · investors recorded per year
2015120161201722018120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in DNA Script?
DNA Script has 6 investors on record on gritt.io, including 2 early-stage backers, 3 mid-stage and 1 late-stage investors.
When did DNA Script last raise funding?
The most recent investment in DNA Script recorded on gritt.io was in December 2020.
When was DNA Script founded?
DNA Script was founded in 2014.
What industry is DNA Script in?
DNA Script operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is DNA Script based?
DNA Script is headquartered in Le Kremlin-Bicêtre, France.